Imcyse SA: Imcyse to present late-breaking abstract of its Imotope™-based antigen-specific immunotherapy for autoimmune diseases at ASIT 2020

Written by Petra Hegmann on 24th February 2020. Posted in Client News.

• Previous
• Next